Publicaciones (36) Publicaciones de GABRIEL BARREDA GOMEZ

2024

  1. Lipid fingerprint-based histology accurately classifies nevus, primary melanoma, and metastatic melanoma samples

    International Journal of Cancer, Vol. 154, Núm. 4, pp. 712-722

  2. Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options

    Journal of Clinical Medicine, Vol. 13, Núm. 6

  3. Serological Antibodies against Kidney, Liver, and Spleen Membrane Antigens as Potential Biomarkers in Patients with Immune Disorders

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

2023

  1. Acute Stress-Induced Changes in the Lipid Composition of Cow’s Milk in Healthy and Pathological Animals

    Molecules, Vol. 28, Núm. 3

  2. Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  3. Dot Immunobinding Assay for the Rapid Serodetection of Scedosporium/Lomentospora in Cystic Fibrosis Patients

    Journal of Fungi, Vol. 9, Núm. 2

  4. Microarrays, Enzymatic Assays, and MALDI-MS for Determining Specific Alterations to Mitochondrial Electron Transport Chain Activity, ROS Formation, and Lipid Composition in a Monkey Model of Parkinson’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 6

  5. Neuroanatomical characterization of the G protein-coupled receptor activity evoked by galanin-related ligands

    Journal of Chemical Neuroanatomy, Vol. 128

  6. Neuroinflammation in the Evolution of Motor Function in Stroke and Trauma Patients: Treatment and Potential Biomarkers

    Current Issues in Molecular Biology, Vol. 45, Núm. 11, pp. 8552-8585

  7. Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Analysis of Mitochondrial Function in Cell Membranes as Indicator of Tissue Vulnerability to Drugs in Humans

    Biomedicines, Vol. 10, Núm. 5

  2. Elevation of Tear MMP-9 Concentration as a Biomarker of Inflammation in Ocular Pathology by Antibody Microarray Immunodetection Assays

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  3. Upregulated phospholipase D2 expression and activity is related to the metastatic properties of melanoma

    Oncology Letters, Vol. 23, Núm. 5

2021

  1. A uhplc-mass spectrometry view of human melanocytic cells uncovers potential lipid biomarkers of melanoma

    International Journal of Molecular Sciences, Vol. 22, Núm. 21

  2. Analysis of Acetylcholinesterase Activity in Cell Membrane Microarrays of Brain Areas as a Screening Tool to Identify Tissue Specific Inhibitors

    Analytica, Vol. 2, Núm. 1, pp. 25-36

  3. Enzyme therapy: Current challenges and future perspectives

    International Journal of Molecular Sciences, Vol. 22, Núm. 17

  4. Ketamina eta esketaminaren erabilera depresioerresistentea tratatzeko: etorkizunerako erronkak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 40, pp. 33-50

  5. Quantification of PD-1/PD-L1 Interaction between Membranes from PBMCs and Melanoma Samples Using Cell Membrane Microarray and Time-Resolved Förster Resonance Energy Transfer

    Analytica, Vol. 2, Núm. 4, pp. 156-170

  6. Study of tissue-specific reactive oxygen species formation by cell membrane microarrays for the characterization of bioactive compounds

    Membranes, Vol. 11, Núm. 12

  7. Subcellular specificity of cannabinoid effects in striatonigral circuits

    Neuron, Vol. 109, Núm. 9, pp. 1513-1526.e11